Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Becerra, Juditha | Fernández, Thalíaa; * | Roca-Stappung, Milenea | Díaz-Comas, Lourdesb | Galán, Lídiceb | Bosch, Jorgeb | Espino, Marbellac | Moreno, Alma Ja | Harmony, Thalíaa
Affiliations: [a] Departamento de Neurociencias Cognitivas y Conductuales, Instituto de Neurobiología, Universidad Nacional Autónoma de México. Juriquilla, Querétaro, México | [b] Centro de Neurociencias de Cuba, Playa, La Habana, Cuba | [c] Centro de Salud Mental, Instituto Mexicano del Seguro Social, Querétaro, Querétaro, México
Correspondence: [*] Correspondence to: Dr. Thalía Fernández, Departamento de Neurociencias Cognitivas y Conductuales, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Campus Juriquilla, Boulevard Juriquilla 3001, Querétaro 76230, México. Tel.: +52 442 238 1051; Fax: +52 442 238 1046; E-mail: [email protected].
Abstract: In normal elderly subjects, the best electroencephalogram (EEG)-based predictor of cognitive impairment is theta EEG activity abnormally high for their age. The goal of this work was to explore the effectiveness of a neurofeedback (NFB) protocol in reducing theta EEG activity in normal elderly subjects who present abnormally high theta absolute power (AP). Fourteen subjects were randomly assigned to either the experimental group or the control group; the experimental group received a reward (tone of 1000 Hz) when the theta AP was reduced, and the control group received a placebo treatment, a random administration of the same tone. The results show that the experimental group exhibits greater improvement in EEG and behavioral measures. However, subjects of the control group also show improved EEG values and in memory, which may be attributed to a placebo effect. However, the effect of the NFB treatment was clear in the EG, although a placebo effect may also have been present.
Keywords: Cognitive impairment, electroencephalogram (EEG) biofeedback, global deterioration scale, healthy aging, neurofeedback, placebo, quantitative electroencephalogram (QEEG)
DOI: 10.3233/JAD-2011-111055
Journal: Journal of Alzheimer's Disease, vol. 28, no. 2, pp. 357-367, 2012
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]